Relationship between methylmalonic acid and cobalamin in uremia

Slides:



Advertisements
Similar presentations
Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup
Advertisements

Volume 59, Issue 3, Pages (March 2001)
Beta blockers in the management of chronic kidney disease
Plasma sodium and hypertension
Intensive hemodialysis—keeping the faith
Volume 70, Issue 8, Pages (October 2006)
S.J. Nessim, S.V. Jassal, S.V. Fung, C.T. Chan  Kidney International 
Volume 70, Issue 3, Pages (August 2006)
Anemia management in chronic kidney disease
Intensive hemodialysis—keeping the faith
Prehypertension and chronic kidney disease: the ox or the plow?
Reassessment of the care of the patient with chronic kidney disease
Volume 75, Issue 11, Pages (June 2009)
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Volume 77, Issue 1, Pages 5-6 (January 2010)
Comorbidity and confounding in end-stage renal disease
Proinflammatory effects of iron sucrose in chronic kidney disease
The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis  Sai Subhodhini Reddy, Jean L. Holley 
Volume 74, Issue 3, Pages (August 2008)
N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment  Martina Franz, Wolfgang Woloszczuk, Walter.
Volume 70, Issue 11, Pages (December 2006)
Body weight is a fluctuating parameter in hemodialysis patients
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
S.J. Nessim, S.V. Jassal, S.V. Fung, C.T. Chan  Kidney International 
Nephrology Crosswords: Hemodialysis
Use of vitamin D in chronic kidney disease patients
Edmund G. Lowrie  Kidney International 
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
Volume 70, Issue 12, Pages (December 2006)
Blood pressure targets in hemodialysis patients
Volume 67, Issue 1, Pages (January 2005)
Fructose intake as a risk factor for kidney stone disease
Joel D. Kopple, Kamyar Kalantar-Zadeh, Rajnish Mehrotra 
Volume 73, Issue 12, Pages (June 2008)
Effects of hemodialysis on cardiac function
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Kidney failure and the gut: p-cresol and the dangers from within
Presentation of the 2003 Jean Hamburger Award to Robert W. Schrier
Alternate-day dialysis may be needed for hemodialysis patients
Methods for guideline development
Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia 
AGEs in foods: Do they play a role in uremia?
Volume 93, Issue 1, Pages (January 2018)
Volume 85, Issue 1, Pages 3-4 (January 2014)
The global challenge of chronic kidney disease
Nephrology Crossword: Glomerulonephritis
V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen 
Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes  Sr. Anne B. Bakewell, Rob M. Higgins, Mair.
Daily nocturnal home hemodialysis
Wei-Teing Chen, Horng-Chin Yan, Fu-Chiu Yu  Kidney International 
Current status of maintenance hemodialysis in Beijing, China
Organ transplantation goes to the movies
Volume 64, Issue 3, Pages (September 2003)
Volume 63, Issue 2, Pages (February 2003)
Volume 66, Issue 1, Pages (July 2004)
Volume 80, Issue 10, Pages (November 2011)
Volume 80, Issue 10, Pages (November 2011)
Volume 64, Issue 5, Pages (November 2003)
Volume 60, Issue 6, Pages (December 2001)
Volume 70, Issue 7, Pages (October 2006)
Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate  S. Aime, C. Canavese, P. Stratta  Kidney International 
Volume 70, Issue 5, Pages (September 2006)
Volume 59, Issue 3, Pages (March 2001)
The International Pediatric Peritonitis Registry: Starting to walk
Evaluation of the Losartan in Hemodialysis (ELHE) Study
Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis.
E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins 
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Peter Stenvinkel, Olof Heimbürger, Catherine H. Tuck, Lars Berglund 
Presentation transcript:

Relationship between methylmalonic acid and cobalamin in uremia Lars Moelby, Karsten Rasmussen, Troels Ring, Gert Nielsen  Kidney International  Volume 57, Issue 1, Pages 265-273 (January 2000) DOI: 10.1046/j.1523-1755.2000.00831.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Serial plasma cobalamin levels in 67 patients on chronic hemodialysis during the course of the 12-month study period. Kidney International 2000 57, 265-273DOI: (10.1046/j.1523-1755.2000.00831.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 Serial plasma methylmalonic acid (MMA) values in 67 uremic patients during the course of the 12-month study period. Kidney International 2000 57, 265-273DOI: (10.1046/j.1523-1755.2000.00831.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Common spline with vitamin B12. Kidney International 2000 57, 265-273DOI: (10.1046/j.1523-1755.2000.00831.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 4 Relationship between MMA and cobalamin in the study population. Kidney International 2000 57, 265-273DOI: (10.1046/j.1523-1755.2000.00831.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.